Our CEO, Dominik Witzigmann, PhD, will be representing NanoVation Therapeutics (NTx) at the RNA Leaders Europe 2024 conference in Basel!

Don’t miss Dom’s presentation “Next-generation LNP technologies for enabling highly effective immunotherapies and vaccines.”

Abstract: The clinical success of LNP-RNA therapies marks a transformative milestone in medicine. At NanoVation Therapeutics, we’re pioneering the next wave of RNA delivery to immune cells for enhanced therapeutic outcomes, both ex vivo and in vivo. Join us as we unveil our groundbreaking LNP platform technologies, charting a clear path to the clinic.

Photos from the event